Purchases and Sales Made in Q4 2023 in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO) during Q4 2023. The information is specifically focused on institutions that hold shares of HALOZYME THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-178K- 11.36% |
$5.93M - $7.5M
|
1.39M
$77.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-189K- 36.31% |
$6.3M - $7.96M
|
332K
$18.5M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-191K- 11.01% |
$6.36M - $8.03M
|
1.54M
$86M
|
|
|
Jan 19, 2024
Q4 2023
|
Redwood Investments, LLC
|
SELL
|
- |
-235K- 71.67% |
$7.84M - $9.91M
|
93.1K
$5.19M
|
|
|
Feb 12, 2024
Q4 2023
|
Eagle Asset Management Inc
St Petersburg, FL |
SELL
|
- |
-343K- 59.65% |
$11.4M - $14.4M
|
232K
$12.9M
|
|
|
Feb 14, 2024
Q4 2023
|
First Light Asset Management, LLC
Edina, MN |
SELL
|
- |
-450K- 77.06% |
$15M - $19M
|
134K
$7.48M
|
|
|
Feb 14, 2024
Q4 2023
|
Snyder Capital Management L P
San Francisco, CA |
SELL
|
- |
-615K- 14.21% |
$20.5M - $25.9M
|
3.71M
$207M
|
|
|
Feb 12, 2024
Q4 2023
|
Artisan Partners Limited Partnership
Milwaukee, WI |
SELL
|
- |
-1.02M- 13.27% |
$34.1M - $43.1M
|
6.69M
$373M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.5M- 82.82% |
$49.9M - $63.1M
|
311K
$17.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-2.08M- 76.29% |
$69.3M - $87.5M
|
646K
$36M
|